Abstract:Summaryo| li]1.|Pharmacological tests of isolated fibers of skeletal muscle proved to be a means of clarifying the occurrence of certain genetic defects. li]2.|Muscle specimens from 74 subjects were investigated. Of these, 14 had recovered from an episode of malignant hyperthermia (MH), an often fatal complication of general anaesthesia which is known to occur on the basis of a genetic predisposition. The others were 25 relatives of MH patients, and 35 subjects unrelated to malignant hyperthermia. li]3.|The tests consisted in measuring the contracture tensions of isolated fibres of skeletal muscle when exposed to various concentrations of caffeine, once in the presence, once in the absence of the anaesthetic agent halothane. The method is described in detail. li]4.|Muscle specimens which in the presence of halothane required more than 1.3 millimolar concentration of caffeine to produce a tension increase of 1 gram were defined as controls. The 45 control data thus defined were normally distributed. Age, sex, type of muscle, and size of the specimen did not account for individual difference within this control population. The control group did not contain any MH patient who had developed rigidity during the attack. On the other hand, it did contain all but one of the specimens from MH-unrelated subjects. li]5.|The acceptance of the control data as a standard left a deviant group of 29 subjects. This group could be subdivided according to the caffeine-contracture in the absence of halothane.All those MH patients who had displayed some rigidity during their attack were in this deviant group; they were characterized by high sensitivity to caffeine. The deviant group included two subjects who had suffered an MH episode without rigidity; they differed from all others by a high resistance to caffeine contracture and thereby seemed to represent a separate category of MH which could not be further analyzed during the studies reported here.The deviant group contained 10 relatives of MH patients who differed in their caffeine response from the patients themselves. Hence there are at least three kinds of relatives of MH patients: those that are indistinguishable from patients, those that fall into the control group, and an intermediate group. One of the MH-unrelated subjects reacted like an intermediate, suggesting that this represents a defect which is not rare in the general population. li]6.|When these data were seen in the context of family groups, there was evidence of a recessively inherited predisposition to malignant hyperthermia. However, part of the data were also compatible with the repeatedly published evidence of dominant inheritance of this predisposition. Since multigenic inheritance appears to be excluded, the simplest genetic models which can reasonably account for the observations are either a two-gene case or the assumption of one gene locus with three alleles. Improvement of the test methods or an increase of the data base should allow a choice between genetic theories.

Next-generation sequencing and bioinformatics to identify genetic causes of malignant hyperthermia

Reduced Threshold for Luminal Ca2+ Activation of RyR1 Underlies a Causal Mechanism of Porcine Malignant Hyperthermia

An Advance in the study of ryanodine receptor mutations and malignant hyperthermia

Recent advances in the diagnosis of malignant hyperthermia susceptibility: How confident can we be of genetic testing?

Screening of the ryanodine receptor type 1 gene in a Chinese pedigree with malignant hyperthermia

Clinical and Genetic Analysis of Essential Hypertension with Mitochondrial Trnamet 4435A>G and YARS2 Mutation.

Molecular Characterization of a Chinese Family Carrying a Novel C4329A Mutation in Mitochondrial Trnaile and Trnagln Genes.

An Association between OXPHOS-Related Gene Expression and Malignant Hyperthermia Susceptibility in Human Skeletal Muscle Biopsies

Author Response for "genetic Spectrum and Clinical Profiles in a Southeast Chinese Cohort of Charcot‐Marie‐Tooth Disease"

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Molecular Genetic Testing for Malignant Hyperthermia Susceptibility

Impaired Interaction Between Skeletal Ryanodine Receptors In Malignant Hyperthermia

Transient Receptor Potential Cation Channels and Calcium Dyshomeostasis in a Mouse Model Relevant to Malignant Hyperthermia

Bioenergetic Defects in Muscle Fibers of RYR1 Mutant Knock-in Mice Associated with Malignant Hyperthermia

Sudden Death Due to Malignant Hyperthermia with a Mutation of RYR1: Autopsy, Morphology and Genetic Analysis.

The caffeine test of isolated human muscle in relation to malignant hyperthermia

Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse.

Variant landscape of the RYR1 gene based on whole genome sequencing of the Singaporean population

Improving molecular diagnosis of Chinese patients with Charcot-Marie-Tooth by targeted next-generation sequencing and functional analysis.

[Application of Targeted Capture Technology and Next Generation Sequencing in Molecular Diagnosis of Inherited Myopathy].

Targeted Next-Generation Sequencing Reveals Hot Spots and Doubly Heterozygous Mutations in Chinese Patients with Familial Cardiomyopathy.